Spectral AI Set to Release Q3 Earnings, Analysts Predict Losses

Spectral AI (NASDAQ: MDAI) is scheduled to announce its financial results for the third quarter of 2025 after market close on November 11, 2025. The company is expected to report a loss of $0.08 per share alongside revenues of approximately $5.0620 million. Investors can access a dedicated overview page for the earnings call, which is set for 5:00 PM ET on the same day.

In its previous earnings report on August 12, 2025, Spectral AI recorded a loss of $0.10 per share, which fell short of the consensus estimate of $0.07 by $0.03. The company’s revenue for that quarter was reported at $5.07 million, compared to expectations of $5.44 million. Analysts forecast that the company will end the current fiscal year with an earnings per share (EPS) of $0 and a projected EPS of $-1 for the following fiscal year.

Stock Performance and Investor Activity

On Friday, shares of MDAI opened at $1.94. The stock has a 50-day simple moving average of $2.17 and a 200-day simple moving average of $2.08. Spectral AI currently holds a market capitalization of $53.58 million, a price-to-earnings ratio of -2.81, and a beta of 0.91. Over the past year, the stock has experienced a low of $1.01 and a high of $3.25.

Institutional trading has seen significant activity, with several large investors adjusting their stakes in Spectral AI. Jane Street Group LLC acquired a new position valued at approximately $74,000 during the second quarter. Marshall Wace LLP and XTX Topco Ltd also entered new positions worth $104,000 and $123,000, respectively. Additionally, Geode Capital Management LLC increased its holdings by 21.8%, now owning 152,958 shares worth around $379,000. Currently, institutional investors and hedge funds hold 67.08% of the company’s stock.

Analyst Ratings and Future Outlook

Recent reports from research analysts provide a mixed outlook for Spectral AI. On October 31, Weiss Ratings reaffirmed a “sell (e+)” rating for the company. Meanwhile, Wall Street Zen downgraded the stock from a “hold” to a “strong sell” rating on August 16. Currently, the consensus rating for Spectral AI is “Hold,” with an average price target of $3.50 according to data from MarketBeat.

Spectral AI focuses on developing predictive medical diagnostics in the United States, particularly aimed at improving treatment decisions in wound care for patients suffering from burns and diabetic foot ulcers. As the company prepares for its upcoming earnings announcement, investors will be monitoring the results closely to gauge its financial health and future growth potential.